Literature DB >> 13356403

A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis.

H ENGELBERG, R KUHN, M STEINMAN.   

Abstract

Entities:  

Keywords:  CORONARY DISEASE/therapy; HEPARIN/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13356403     DOI： 10.1161/01.cir.13.4.489

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  SOME SEQUELS TO MYOCARDIAL INFARCTION AND THEIR TREATMENT.

Authors:  R R LOVELL
Journal:  Br Med J       Date:  1964-08-22

2.  [ANTILIPEMIC EFFECT OF ACID SODIUM HEPARIN AFTER SUBLINGUAL OR RECTAL ADMINISTRATION].

Authors:  H SCHOELL; F KOPITZKI
Journal:  Klin Wochenschr       Date:  1964-07-15

3.  [Histological & histochemical changes in temporary monoiodoacete induced alopecia: experimental study].

Authors:  O BRAUN-FALCO; H THEISEN
Journal:  Arch Klin Exp Dermatol       Date:  1959

4.  [On changes of skin connective tissue during the hair growth cycle in the mouse].

Authors:  O BRAUN-FALCO; H THEISEN
Journal:  Arch Klin Exp Dermatol       Date:  1959

5.  Alopecia following treatment with dextran sulphate and other anticoagulant drugs.

Authors:  G R TUDHOPE; H COHEN; R W MEIKLE
Journal:  Br Med J       Date:  1958-05-03

Review 6.  Modification of atherosclerosis by agents that do not lower cholesterol.

Authors:  J G Cleland; D M Krikler
Journal:  Br Heart J       Date:  1993-01

7.  Inhibition of leucocyte elastase by heparin and its derivatives.

Authors:  F Redini; J M Tixier; M Petitou; J Choay; L Robert; W Hornebeck
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

8.  Heparan sulfate proteoglycans present PCSK9 to the LDL receptor.

Authors:  Camilla Gustafsen; Ditte Olsen; Joachim Vilstrup; Signe Lund; Anika Reinhardt; Niels Wellner; Torben Larsen; Christian B F Andersen; Kathrin Weyer; Jin-Ping Li; Peter H Seeberger; Søren Thirup; Peder Madsen; Simon Glerup
Journal:  Nat Commun       Date:  2017-09-11       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.